Skip to main content
Log in

Clinical significance of antinucleosome antibodies in Tunisian systemic lupus erythematosus patients

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

The aim of this study was to investigate the clinical significance of antinucleosome antibodies in Tunisian systemic lupus erythematosus (SLE) patients. IgG antinucleosome antibodies were detected by a qualitative enzyme immunoassay (immunodot) in the sera of SLE patients at onset of disease. The patients were divided into two groups according to the result of the antinucleosome antibodies test: positive (group A) and negative (group B). The two groups were also evaluated for clinical and biological parameters. Of 84 patients with SLE, 66 (78.6%) had antinucleosome antibodies. Among 21 patients negative for anti-double-stranded DNA (anti-dsDNA), 5 (23.8%) were antinucleosome positive. The most common initial features were haematological disorders (80.1%) and arthritis or arthralgias (79.8%). Renal disorders, observed in 59.5% of SLE patients, were more common in group A compared to group B (65 vs 38%) (p=0.04). The European Consensus Lupus Activity Measurement (ECLAM) mean score was higher in group A (6.42) than in group B (4.44) (p=0.002). Antinucleosome antibodies were positive in nearly one-fourth of SLE patients negative for anti-dsDNA. We found a correlation between antinucleosome antibodies, nephritis and SLE disease activity. Therefore, the determination of circulating antinucleosome antibodies could be a useful parameter for early diagnosis and follow-up of SLE patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Tan EM (1989) Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 44:93–151

    CAS  PubMed  Google Scholar 

  2. Mohan C, Adams S, Stanik V, Datta SK (1993) Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J Exp Med 177:1367–1381

    Article  CAS  PubMed  Google Scholar 

  3. Luger K, Mader AW, Richmond RK, Sargent DF, Richmond TJ (1997) Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 389:251–260

    Article  CAS  PubMed  Google Scholar 

  4. Amoura Z, Chabre H, Koutouzov S, Lotton C, Cabrespines A, Bach JF, Jacob L (1994) Nucleosome-restricted antibodies are detected before anti-dsDNA and/or antihistone antibodies in serum of MRL-Mp lpr/lpr and +/+ mice, and are present in kidney eluates of lupus mice with proteinuria. Arthritis Rheum 37:1684–1688

    CAS  PubMed  Google Scholar 

  5. Kramers C, Hylkema MN, Van Bruggen MC, Van de Lagemaat R, Dijkman HB, Assmann KJ et al (1994) Anti-nucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membrane in vivo. J Clin Invest 94:568–577

    CAS  PubMed  Google Scholar 

  6. Burlingame RW, Boey ML, Starkebaum G, Rubin RL (1994) The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus. J Clin Invest 94:184–192

    CAS  PubMed  Google Scholar 

  7. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725

    CAS  Google Scholar 

  8. Vitali C, Bencivelli W, Isenberg DA, Smolen JS, Snaith ML, Sciuto M et al (1992) Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of variables indicative of disease activity and their use in the development of an activity score. The European Consensus Study Group for Disease Activity in SLE. Clin Exp Rheumatol 10:541–547

    CAS  PubMed  Google Scholar 

  9. Churg J, Bernstein J, Glassock RJ (1995) Lupus nephritis. In: Renal disease: classification and atlas of glomerular diseases, 2nd edn. Igaku-Shoin Medical Publishers, New York, pp 51–79

  10. Emlen W, Holers VM, Arend WP, Kotzin B (1992) Regulation of nuclear antigen expression on the cell surface of human monocytes. J Immunol 148:3042–3048

    CAS  PubMed  Google Scholar 

  11. Andreassen K, Bredholt G, Moens U, Bendiksen S, Kauric G, Rekvig OP (1999) T cell lines specific for polyomavirus T-antigen recognize T-antigen complexed with nucleosomes: a molecular basis for anti-DNA antibody production. Eur J Immunol 29:2715–2728

    Article  CAS  PubMed  Google Scholar 

  12. Amoura Z, Koutouzov S, Chabre H, Cacoub P, Amoura I, Musset L et al (2000) Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases. Antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus. Arthritis Rheum 43:76–84

    Article  CAS  PubMed  Google Scholar 

  13. Bruns A, Blass S, Hausdorf G, Burmester GR, Hiepe F (2000) Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus. Arthritis Rheum 43:2307–2315

    Article  CAS  PubMed  Google Scholar 

  14. Cairns AP, McMillan SA, Crockard AD, Meenagh GK, Duffy EM, Armstrong DJ, Bell AL (2003) Antinucleosome antibodies in the diagnosis of systemic lupus erythematosus. Ann Rheum Dis 62:272–273

    Article  CAS  PubMed  Google Scholar 

  15. Min DJ, Kim SJ, Park SH, Seo YI, Kang HJ, Kim WU et al (2002) Anti-nucleosome antibody: significance in lupus patients lacking anti-double-stranded DNA antibody. Clin Exp Rheumatol 20:13–18

    CAS  PubMed  Google Scholar 

  16. Benucci M, Gobbi FL, Del Rosso A, Cesaretti S, Niccoli L, Cantini F (2003) Disease activity and antinucleosome antibodies in systemic lupus erythematosus. Scand J Rheumatol 32:42–45

    Article  PubMed  Google Scholar 

  17. Burlingame RW, Rubin RL, Balderas RS, Theofilopoulos AN (1993) Genesis and evolution of antichromatin autoantibodies in murine lupus implicates T-dependent immunization with self antigen. J Clin Invest 91:1687–1696

    CAS  PubMed  Google Scholar 

  18. Abraham-Simon J, Rojas-Serrano J, Cabiedes J, Alcocer-Varela J (2004) Antinucleosome antibodies may help predict development of systemic lupus erythematosus in patients with primary antiphospholipid syndrome. Lupus 13:177–181

    CAS  PubMed  Google Scholar 

  19. Suenaga R, Abdou NI (1996) Anti-(DNA-histone) antibodies in active lupus nephritis. J Rheumatol 23:279–284

    CAS  PubMed  Google Scholar 

  20. Van Bruggen MC, Kramers C, Hylkema MN, Smeenk RJ, Berden JH (1996) Significance of anti-nuclear and anti-extracellular matrix autoantibodies for albuminuria in murine lupus nephritis; a longitudinal study on plasma and glomerular eluates in MRL/l mice. Clin Exp Immunol 105:132–139

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors wish to thank Mrs. Ben Hamed Nadia for her assistance in revising the manuscript and Mrs. El Abed Souad and Boukthir Samia for their excellent technical assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H. Masmoudi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Haddouk, S., Ben Ayed, M., Baklouti, S. et al. Clinical significance of antinucleosome antibodies in Tunisian systemic lupus erythematosus patients. Clin Rheumatol 24, 219–222 (2005). https://doi.org/10.1007/s10067-004-1005-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-004-1005-5

Keywords

Navigation